Minimally Manipulated Bone Marrow-Derived Cells Can Be Used for Tissue Engineering In Situ and Simultaneous Formation of Personalized Tissue Models

Bull Exp Biol Med. 2022 May;173(1):139-145. doi: 10.1007/s10517-022-05509-z. Epub 2022 May 27.

Abstract

Red bone marrow and autologous bone tissue (bone fragments and bone chips) of the donor were harvested intraoperatively during autoplasty of talus bone defect. Titanium chips were obtained by grinding a fragment of a microporous titanium-coated hip arthroplasty (Zimmer). Bone marrow mononuclear cells were isolated in the operating room, and bone and titanium fragments were incubated with a suspension of mononuclear cells. The quality of revitalization was assessed by fluorescence microscopy and histological examination after culturing of adherent cells on the bone and titanium fragments. During culturing on bone chips, bone marrow mononuclear fraction cells demonstrated significantly higher metabolic activity than bone marrow cells (p=0.04). Mononuclear fraction cells were also capable of stable colonization of titanium fragments with the formation of composite tissue model.

Keywords: bone marrow mononuclear cells; bone regeneration; in situ; tissue engineering; tissue models.

MeSH terms

  • Bone Marrow
  • Bone Marrow Cells
  • Tissue Engineering*
  • Titanium*
  • Transplantation, Autologous

Substances

  • Titanium